Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

INHANCETM Reverse Glenoid Peripheral Posts

K-Number: K221467 · 2022-08-31

Decision Date2022-08-31
Product CodePHX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

INHANCETM Reverse Glenoid Peripheral Posts is a medical device manufactured by Depuy Ireland UC. It received FDA 510(k) clearance on 2022-08-31 under approval number K221467. The device is classified under product code PHX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the INHANCETM Reverse Glenoid Peripheral Posts?

INHANCETM Reverse Glenoid Peripheral Posts is a medical device that received FDA 510(k) clearance on 2022-08-31. It is manufactured by Depuy Ireland UC. The 510(k) number is K221467.

When was INHANCETM Reverse Glenoid Peripheral Posts approved by the FDA?

INHANCETM Reverse Glenoid Peripheral Posts received FDA 510(k) clearance on 2022-08-31, under approval number K221467.

What company makes INHANCETM Reverse Glenoid Peripheral Posts?

INHANCETM Reverse Glenoid Peripheral Posts is manufactured by Depuy Ireland UC.

What is the FDA product code for INHANCETM Reverse Glenoid Peripheral Posts?

The FDA product code for INHANCETM Reverse Glenoid Peripheral Posts is PHX.

Related Clinical Trials

Other Devices by Depuy Ireland UC

View all 48 devices →

Related Devices (Code: PHX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.